When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...

Shares of gene therapy developer uniQure N.V. (QURE) shot up 41% on Thursday afternoon after it announced that the U.S. Food ...

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.

A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than ...

CGT Catapult is an independent technology and innovation organization specializing in the advancement of the cell and gene therapy ... Application (MAA) submissions. The Company believes that ...

R&D Grade: Primarily utilized in preclinical studies and research applications, this segment plays a crucial role in the early stages of therapeutic development. Cell & Gene Therapy: This segment held ...

On the heels of its acquisition by Ocuphire Pharma, Opus is planning next steps for its Leber congenital amaurosis type 5 ...

Belief BioMed Inc. (BBM) is a global biotech company that integrates the research and development (R&D), manufacturing and clinical application of gene therapy products. The company is committed ...